California Public Employees Retirement System Reduces Stake in ICU Medical, Inc. (NASDAQ:ICUI)

California Public Employees Retirement System trimmed its holdings in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 14.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 33,874 shares of the medical instruments supplier's stock after selling 5,739 shares during the quarter. California Public Employees Retirement System owned 0.14% of ICU Medical worth $5,256,000 at the end of the most recent reporting period.

Several other large investors have also recently modified their holdings of ICUI. Harvest Fund Management Co. Ltd purchased a new stake in shares of ICU Medical during the 4th quarter worth $33,000. Murphy & Mullick Capital Management Corp acquired a new stake in shares of ICU Medical during the fourth quarter worth about $52,000. Venturi Wealth Management LLC increased its stake in shares of ICU Medical by 64.0% in the fourth quarter. Venturi Wealth Management LLC now owns 528 shares of the medical instruments supplier's stock worth $82,000 after acquiring an additional 206 shares during the period. Smartleaf Asset Management LLC grew its stake in shares of ICU Medical by 166.8% during the 4th quarter. Smartleaf Asset Management LLC now owns 907 shares of the medical instruments supplier's stock worth $140,000 after purchasing an additional 567 shares during the period. Finally, Coldstream Capital Management Inc. purchased a new position in ICU Medical in the third quarter valued at $227,000. Institutional investors own 96.10% of the company's stock.

Wall Street Analyst Weigh In

ICUI has been the subject of a number of research analyst reports. StockNews.com raised ICU Medical from a "hold" rating to a "buy" rating in a report on Friday, April 4th. Raymond James set a $97.00 price objective on shares of ICU Medical in a research report on Wednesday, March 12th. Finally, Needham & Company LLC reissued a "hold" rating on shares of ICU Medical in a research report on Tuesday, April 8th. One analyst has rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Buy" and an average price target of $168.67.

Remove Ads

ICU Medical Price Performance

Shares of ICU Medical stock traded up $0.01 during trading on Monday, reaching $142.66. The company's stock had a trading volume of 5,908 shares, compared to its average volume of 261,607. The business has a 50 day moving average price of $148.29 and a 200-day moving average price of $160.86. The company has a market capitalization of $3.50 billion, a P/E ratio of -31.08 and a beta of 0.86. The company has a quick ratio of 1.03, a current ratio of 2.29 and a debt-to-equity ratio of 0.75. ICU Medical, Inc. has a 12-month low of $93.36 and a 12-month high of $196.26.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.